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Abstract
Introduction:  An  alarming  rise  of  obesity  in  adolescents  has  been  observed,  placing  them  at  risk
of developing  resistance  to  insulin  (IR)  and  its  adverse  metabolic  consequences  such  as  diabetes
mellitus type  2  (DM2),  metabolic  syndrome  and  cardiovascular  disease.
Objective:  To  know  the  prevalence  of  obesity,  and  the  levels  of  glucose,  insulin  and  HOMA-IR
and its  association  with  the  BMIz,  waist  circumference  and  the  pubertal  stage  in  a  random
sample of  adolescents.
Materials  and  methods: 292  adolescents  between  12  and  15  years  (152  female  and  140  male),
whose anthropometric  measurements  (weight,  height  and  waist  circumference)  were  taken,
body mass  index  calculated  and  Z-score  determined.  Blood  glucose  and  insulin  levels  were
evaluated  from  a  sample  of  blood  and  their  HOMA-IR  was  determined.
Results:  The  results  showed  that  32.5%  were  obese,  22.3%  were  overweight  and  23.6%
showed adolescent  central  obesity.  Glucose  levels  (p  =  0.016),  insulin  (p  =  0.0001)  and  HOMA-IR
(p =  0.0001)  showed  signiﬁcant  differences  in  the  group  with  obesity.  Values  of  the  three  param-
eters were  increased  with  the  stage  of  puberty.  We  found  signiﬁcant  differences  in  the  levels
of glucose  (p  =  0.0388),  insulin  (p  =  0.0005)  and  HOMA-IR  (p  =  0.0001)  between  the  prepubertal
and postpubertal  stages.∗ Corresponding author at: Universidad Autónoma de Coahuila, Facultad de Ciencias Químicas, Laboratorio de Análisis Clínicos. Blvd.
enustiano Carranza s/n, colonia República, Saltillo, Coahuila C.P. 25280, Mexico. Tel.: +52 8444169213; fax: +52 8444159534.
E-mail address: mantoniagz@yahoo.com.mx (M.A. González-Zavala).
ttp://dx.doi.org/10.1016/j.rmu.2015.02.004
665-5796/© 2014 Universidad Autónoma de Nuevo León. Published by Masson Doyma México S.A. This is an open access article under the
C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Conclusion:  The  results  showed  that  the  presence  of  central  obesity,  overweightness  and  obe-
sity are  closely  associated  with  the  prevalence  of  IR,  and  may  be  signiﬁcant  predictors  of
DM2.
© 2014  Universidad  Autónoma  de  Nuevo  León.  Published  by  Masson  Doyma
México S.A.  This  is  an  open  access  article  under  the  CC  BY-NC-ND  license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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iIntroduction
Obesity  in  children  and  adolescents  is  an  international
health  problem.  The  relationship  between  it  and  the  devel-
opment  of  metabolic  alterations  like  insulin  resistance  (IR),
Diabetes  Mellitus  type  2  (DM2),  dyslipidemias  and  cardio-
vascular  diseases  (CVD)  is  well  known.  In  the  IR  stage,
a  compensating  increase  of  insulin  is  produced,  with  the
objective  of  maintaining  the  homeostasis  of  glucose  (GL).
This  stage  of  chronic  hyperinsulinemia,  in  the  long  term,
leads  to  the  development  of  DM2,  metabolic  syndrome  (MS)
and  CVD.1--6 Obesity  with  an  excess  of  adipose  tissue,  mainly
visceral,  creates  a  determining  factor  in  the  establishment
of  IR,  since  this  tissue,  in  addition  to  fulﬁlling  its  duties
of  energetic  storage,  exercises  other  activities  involved
in  homeostatic  maintenance.  The  visceral  adipose  tissue
presents  a  greater  amount  of  adrenergic  beta  receptors  than
the  subcutaneous  tissue,  signiﬁcantly  favoring  the  lipolytic
activity  in  this  zone  of  the  adipose  tissue,  generating  a  larger
output  of  free  fatty  acids  toward  the  portal  circulation  and
liver,  contributing  to  the  establishment  of  insulin  resistance
in  hepatic,  muscular  and  pancreatic  tissue.  Additionally,  the
adipose  tissue  produces  pro-inﬂammatory  cytokines  such  as
adipokines,  among  which  are  interleukin-6  (IL-6)  and  tumor
necrosis  factor  alpha  (TNF-) which  blocks  the  cascade  of
insulin  signaling  (INS).  IL-6  and  TNF- promote  lipolysis  in
adipose  tissue,  favoring  portal  circulation  which  ﬂoods  the
liver  and  other  tissues  with  more  free  fatty  acids,  which
contributes  to  RI.7--10 INS  sensitivity  varies  in  the  differ-
ent  stages  from  childhood  to  adolescence.  In  children  and
adolescents,  RI  is  the  key  element  in  MS  associated  with
obesity,  and  it  is  usually  present  for  many  years  before  the
onset  of  abnormalities  like  GL  intolerance,  dyslipidemia,
hypertension,  DM2  and  CVD.11--13 In  Mexico,  according  to
the  National  Survey  of  Health  and  Nutrition  2012  (ENSANUT
by  its  Spanish  acronym),  the  combined  prevalence  of  over-
weightness  and  obesity  in  adolescents  between  12  and  19
years  of  age  is  35%,  35.8%  (3  175  711)  for  females  and
34.1%  (3  148  146)  for  males.14 The  HOMA  index  (Homeostatic
Model  Assessment),  built  by  Matthews  (HOMA-IR),  is  the
most  utilized  method  to  determine  IR.15--19 Nationally  and
internationally,  there  is  no  consensus  related  to  the  average
values  of  INS  and  HOMA-IR  in  children  and  healthy  ado-
lescents,  thus  causing  researchers  to  establish  non-uniform
criteria  and  take  previously  conducted  studies  in  different
populations  as  a  reference.  INS  levels  in  eutrophic  chil-
dren  and  adolescents  have  been  reported  by  Viso  et  al.
(2004)  to  be  5.47  ±  2.46  UI/mL.20 Morales  et  al.  (2007)
reported  6.15  ±  1.97  UI/mL,21 Souki-Rincón  et  al.  reported
w
b
i
m3.0  ±  0.5  UI/mL22 and  Marcos-Daccarett  et  al.  reported
.0  ±  3.9  UI/mL.23 Goran  and  Gower,  after  insulinemia
easurement  studies  in  the  pubertal  stage,  established
ome  cut  points.  They  determined  for  the  prepubertal  stage
Tanner  1  stage)  insulinemia  values  ≥15  UI/mL,  for  middle
repubertal  (Tanner  2--4  stage)  values  ≥30  UI/m,  and  post-
ubertal  (Tanner  4--5  stage)  values  of  ≥  a  20  UI/mL.24 Other
esearchers  determined  their  own  cut  levels  for  their  respec-
ive  areas  of  study,  estimating  tables  with  percentiles.
owever,  the  lack  of  these  tables  in  an  important  group  of
ountries  for  pediatric  ages  prevents  uniform  criteria  from
eing  established.11,25 The  same  situation  occurs  for  the  cut
oint  in  IR  diagnosis.  In  2005  Kinski  et  al.  reported  HOMA-IR
3.16  and  Hirschler  et  al.  reported  it  as  >3.29.26,27 Anthro-
ometry  is  used  in  order  to  evaluate  the  degree  of  obesity,
ike  the  body  mass  index  (BMI)  calculating  its  Z  score  (BMIz)
nd  the  measurement  of  the  circumference  of  the  waist
CW).3,28--30 Therefore,  the  objective  of  the  present  inves-
igation  was  to  know  the  prevalence  of  OW,  OB  and  COB,  GL
nd  INS  levels,  HOMA-IR  and  its  connection  to  BMIz,  CW  and
he  pubertal  stage  in  adolescents  between  12  and  15  years
f  age  in  Saltillo,  Coahuila,  Mexico.
aterials and methods
he  present  investigation  is  descriptive/transversal.  A  total
f  292  adolescents  were  randomly  analyzed  between  2012
nd  2013  from  5  public  junior  high  schools  of  Saltillo,
oahuila,  Mexico,  with  ages  ranging  between  12  and  15,
ho  participated  voluntarily  with  an  informed  consent
igned  by  their  parents  or  tutors.  Adolescents  who  suffered
rom  any  sort  of  systemic  or  endocrinological  chronic  dis-
ase  were  excluded  because  they  could  alter  the  analytic
esults.  Physical  and  anthropometric  exams  were  performed
n  order  to  determine  their  nutritional  stage  and  puber-
al  stage,  according  to  Marshall  and  Tanner.31,32 Regarding
nthropometric  measurements,  size  was  measured  using  the
tadimeter  (206  SECA  BODYMETER,  SECA  AYN.  Germany)  in
 standing  position,  with  their  backs  toward  the  front,  bare-
oot,  and  the  measurement  was  registered  in  centimeters.
he  measurement  of  weight  was  performed  using  a  digi-
al  scale  with  a  capacity  of  150  kg  (Tanita  TFB  300,  Tanita
orporation,  Arlington  Heights,  IL,  60005,  USA)  with  the
inimum  amount  of  clothing  on,  without  shoes,  registered
n  kilograms  and  grams.  The  circumference  of  the  waist
as  performed  with  an  anthropometric  ﬂexible,  inextensi-
le  tape  (Lufkin  W606PM  Lufkin,  USA),  with  the  adolescent
n  a  standing  position,  arms  relaxed  on  the  side  of  the  body,
easurement  in  the  middle  point  between  the  costal  edge
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Table  1  Adolescents  classiﬁed  by  BMIz  in  general  and  by  gender  Saltillo,  Coahuila,  Mexico  (2012--2013).
Gender  Total  Low  weight  Normal  weight  Overweight  Obese  Morbidly  obese
n  %  n  %  n  %  n  %  n  %  n  %
General  292  100  22  7.5  110  37.7  65  22.3  78  26.7  17  5.8
Female 152  52  14  9.2  59  38.8  32  21.1  40  26.3  7  4.6
Male 140  48  8  5.7  51  36.4  33  23.6  38  27.2  10  7.1
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(nd  the  iliac  crest,  breathing  out,  and  considering  the  cutoff
oint  >90  percentile  for  central  obesity.33 Moreover,  BMI  was
alculated  using  the  formula  weight/height2 and  the  Z  score
as  evaluated  (BMIz)  in  order  to  classify  their  nutritional
tate  using  the  charts  of  the  WHO.  The  Z  score  is  expressed
n  units  of  standard  deviation  (SD);  a  Z  score  between  −2
nd  −3  SD  corresponds  to  severe  low  weight,  between  −1
nd  −2  SD  corresponds  to  low  weight,  between  +1  and  −1
D  corresponds  to  normal  weight,  between  +1  and  +1  SD
orresponds  to  overweight,  between  +2  and  +3  SD  corre-
ponds  to  obesity  and  greater  than  +3  SD  corresponds  to
orbid  obesity.34 Blood  was  obtained  via  venous  puncture
ith  a  previous  fasting  of  at  least  12  h.  The  samples  were
entrifuged  at  35  000  rpm  for  15  min  in  refrigerated  cen-
rifuge  at  6 ◦C  (Thermo  Scientiﬁc  SL,  16R,  USA);  the  serum
as  conserved  at  4 ◦C  up  to  the  moment  of  processing  of
he  GL  on  the  same  day  as  extraction.  An  aliquot  was  pre-
erved  at  −21 ◦C  for  two  days  to  perform  the  INS  analysis.
he  determination  of  the  GL  was  conducted  in  automatized
‘Diconex’’  equipment  InCCA  (Intelligent  Clinical  Chemistry
nalyzer)  (Diconex,  USA)  through  the  enzymatic  method
conversion  to  gluconate-6-phosphate  by  hexokinase  and
lucose-6-phosphate-dehydrogenase  in  presence  of  ATP  and
AD)  with  Human  reactives.
INS  analysis  was  made  with  the  automated  equipment
OSOH  AIA-600  (Tokyo,  Japan)  by  an  IFALS  (Immunoﬂuo-
escence  assay  with  labeled  substrate)  immunoassay  with
OSOH  reactives.  We  used  high-  and  low-level  commercial-
rade  controls  (Human  brand)  in  both  tests.  The  index  of  the
omeostatic  model  was  calculated  with  the  Matthews  for-
ula:  HOMA  =  [Glucose  (mmol/L)  ×  Insulin  (U/mL)/22.5].
e  used  the  FID  criteria  for  the  fasting  GL  cutoff  point
alue  ≥100  mg/dL,35 and  for  the  fasting  INS  for  the  pre-
ubertal  state  insulinemia  values  of  ≥15  UI/mL,  for  the
iddle  pubertal  ≥30  mU/mL  and  for  the  postpubertal
20  mU/mL.24 We  considered  that  the  level  of  RI  that  pre-
icts  a  greater  rick  of  DM-2  was  HOMA-IR  ≥3.16.26 The  results
ere  expressed  as  an  average,  standard  deviation  (SD)  and
he  analysis  of  the  variables  with  the  number  of  cases  and  a
ercentage.  We  compared  the  average  between  the  groups
ith  the  Student’s  t  test;  for  more  than  2  groups  and  the
omparison  of  multiples  groups,  we  employed  the  variation
nalysis  (ANOVA,  test  by  Tukey).  The  results  were  considered
tatistically  signiﬁcant  with  a  value  of  p  ≤  0.05.  The  pre-
ictability  of  the  AUS  to  evaluate  the  efﬁcacy  of  the  HOMA-IR
ndex  as  an  indicator  of  IR  was  determined  by  the  analysis
f  the  ROCC  (Receiver  Operating  Characteristic  Curve)  for
utoff  values  of  3.16.  The  Minitab  16,  GrapPad  Prism  5  and
PSS  21  programs  were  used  to  make  the  statistical  analysis
f  the  results.
t
a
results
ut  of  the  292  analyzed  adolescents,  52%  were  women  (152)
nd  48%  were  men  (140),  with  a  mean  age  of  13.02  ±  0.94
ears,  a  mean  weight  of  60.02  ±  15.69  kg  (27.2--120.3)  and  a
ean  size  of  158.34  ±  8.03  cm  (125--179).  The  prevalence  of
entral  obesity  (percentile  >90)  was  at  23.6%  corresponding
o  49.3%  for  females  and  50.7%  for  males.  According  to  their
MIz,  over  half  of  the  adolescents  presented  overweight-
ess  and  obesity,  this  abnormality  being  more  predominant
n  males  (Table  1).
The  mean  values  obtained  by  the  biochemical  param-
ters  in  our  general  sample  were  the  following:  GL
5.8  ±  11.8  mg/dL,  the  percentage  above  ≥100  was  11.5%,
NS  level  was  13.2  ±  10.5  UI/mL  and  the  HOMA-IR  value
as  2.9  ±  2.5  with  a  46%  over  ≥3.16.  When  analyzing
he  results  by  gender,  we  found  that  for  females,  GL
as  83.4  ±  11.2  mg/dL,  INS  13.4  ±  10.2  UI/mL  and  HOMA-
R  2.9  ±  2.5,  while  for  males,  GL  was  88.5  ±  11.8  mg/dL,
NS  12.9  ±  10.8  UI/mL  and  HOMA-IR  2.9  ±  2.5.  We  found
tatistically  signiﬁcant  differences  between  genders  for
L  (p  =  0.0002)  but  not  for  INS  (p  =  0.6582)  and  HOMA-IR
p  =  0.9965).  After  studying  the  results  of  the  biochemical
arameters  concerning  BMIz,  we  noticed  that  the  values
ncreased  as  BMIz  did,  presenting  the  highest  values  in  OB
Table  2).  After  evaluating  HOMA-IR  results,  we  found  it
otoriously  high  in  OB  (p  ≤  0.0001).  There  were  statistically
igniﬁcant  differences  in  GL  (p  =  0.0161),  INS  (p  ≤  0.0001)
nd  HOMA-IR  levels  (p  ≤  0.0001)  between  the  different  BMIz
roups.
After  examining  the  results  of  three  biochemical  param-
ters  by  gender  and  BMIz,  it  was  noted  that  the  percentage
f  the  highest  values  was  observed  in  the  OW  and  OB  of
oth  genders.  We  noticed  statistically  signiﬁcant  differences
etween  genders  with  OW  regarding  GL  levels  (p  =  0.0046)
nd  none  in  INS  levels  (p  =  0.3006)  or  the  HOMA-IR  value
p  =  0.1015).  Regarding  OB,  no  statistically  signiﬁcant  differ-
nces  between  genders  were  observed  for  GL  (p  =  0.0551),
NS  (p  =  0.3150)  and  HOMA-IR  levels  (p  =  0.6537).
After  analyzing  the  results  of  the  three  parameters  in
elationship  with  pubertal  development,  it  was  observed
hat  the  values  increased  when  pubertal  development  was
aised  (Table  3).  There  was  a  statistically  signiﬁcant  dif-
erence  between  the  prepubertal  and  the  postpubertal  in
elationship  with  GL  levels  (p  =  0.0247),  but  not  in  INS
p  =  0.4398)  or  HOMA-IR  (p  =  0.2255).  HOMA-IR  values  showed
hat  approximately  half  the  studied  adolescents  (pubertal
nd  postpubertal)  presented  IR.
The  study  of  the  results  of  the  biochemical  parameters
egarding  pubertal  development  by  gender  revealed  that
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Table  2  Glucose,  insulin  and  HOMA-IR  by  BMIz  Saltillo,  Coahuila,  Mexico  (2012--2013).
BMIz  Glucose  (mg/dL)  Insulin  (UI/mL)  HOMA-IR  (UI/mL  ×  mmol/L)
n  Average  %a p  Averge  p  Average  %a p
(42--121) (2,3--91.6)  (0,3--20,3)
Low  weight 22  82.5  ±  9.50  3.4  0.0271  6.4  ±  3.0  <0.0001  1.3  ±  0.6  0.04  <0.0001
Normal weight 110  85.2  ±  11.8 10.6 0.0367 8.0  ±  4.0  <0.0001  1.8  ±  1.3  10.7  <0.0001
Overweight 65  83.7  ±  10.6 6.4 0.0081 11.5  ±  5.7 <0.0001  2.4  ±  1.3  21.4  <0.0001
Obese 95  88.8  ±  12.4  18.5  0.0161* 21.9  ±  13.2  <0.0001* 4.9  ±  3.1  66.9  <0.0001*
a % of values above the cutoff point. Cutoff points: Glucose ≥100 mg/dL; insulin: was not evaluated, there are no cutoff points for this
biochemical parameter in relation to BMI; HOMA-IR ≥3.16. For the value of p we collated all the IMCz against that of Obesity (t-Student).
* ANOVA.
Table  3  Glucose,  insulin  and  HOMA-IR  by  pubertal  stage  Saltillo,  Coahuila,  Mexico  (2012--2013).
Pubertal  stage
(Tanner)
n  Glucose  (mg/dL)  Insulin  (UI/mL)  HOMA-IR  (UI/mL  ×  mmol/L)
Average  %a p  Average  %a p  Average  %a p
Prepubertal  16  83.5  ±  11.3  7.6  0.0388  10.6  ±  4.4  16.2  0.235  2.3  ±  1.3  21.3  0.1665
Middle pubertal  216  85.0  ±  12.1  10.9  0.0097  13.1  ±  10.3  5.1  0.4502  2.8  ±  2.4  44.7  0.182
Postpubertal 60  89.5  ±  9.7  14  0.0247* 14.3  ±  12.0  31.8  0.4398* 3.3  ±  3.0  52.3  0.2255*
a % of values above the cutoff point. Cutoff points: glucose ≥100 mg/dL; insulin: prepubertal ≥15 mU/mL, middle pubertal ≥30 mU/mL,
collat
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This  study  showed  an  elevated  prevalence  of  overweight-
ness  (22.3%),  obesity  (32.5%),  central  obesity  (23.6%)  and
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Specificitypostpubertal ≥20 mU/mL; HOMA-IR ≥3.16. For the value of p we 
* ANOVA.
the  highest  values  in  females  occurred  in  the  postpubertal
stage,  while  in  males  the  highest  values  for  INS  and  HOMA-IR
occurred  in  the  pubertal  stage  and  the  highest  values  for  GL
occurred  in  the  postpubertal  stage  (Table  4).
The  results  of  each  of  the  parameters  were  compared
with  each  pubertal  stage  by  gender;  we  found  that  there
were  no  statistically  signiﬁcant  differences  in  the  prepuber-
tal  stage,  while  in  the  pubertal  stage  there  were  differences
in  GL  (p  ≤  0.0001)  and  HOMA-IR  (p  =  0.0408)  and  differences
in  INS  (p  =  0.0085)  and  HOMA-IR  (p  =  0.0101)  in  the  postpu-
bertal  stage  were  also  observed.
Mean  values  obtained  from  the  three  biochemical  param-
eters  concerning  adolescents  without  COB  (76.4%)  were  GL
84.2  ±  11.4  mg/dL,  HOMA-IR  2.1  ±  1.5  with  8.5  and  24.2%
of  values  over  the  cutoff  points,  respectively,  and  INS
9.9  ±  6.1  UI/mL.  For  adolescents  with  COB  (23.6%),  GL
was  91.1  ±  11.2  mg/dL,  HOMA-IR  5.4  ±  3.4  with  21.3  and
74.4%  of  values  over  the  cutoff  points,  respectively,  and  INS
23.7  ±  14.2  UI/mL.  When  the  results  of  the  three  biochem-
ical  parameters  of  adolescents  with  and  without  COB  were
compared,  there  were  statistically  signiﬁcant  differences  in
all  three  parameters  (p  ≤  0.0001).
Concerning  COB  prevalence  and  pubertal  stage,  it  was
reported  that  6.7%  occurred  in  the  prepubertal  stage,  22.2%
in  the  pubertal  stage  and  33.3%  in  the  postpubertal  stage.
When  the  results  of  the  biochemical  parameters  were  asso-
ciated  with  pubertal  stage  and  waist  circumference,  it  was
noted  that  in  all  pubertal  stages,  the  adolescents  who  dis-
played  COB  presented  higher  values,  observing  a  high  IR
incidence  in  pubertal  and  postpubertal  stages  (Table  5).
When  performing  a  comparative  study  of  the  results  of
the  biochemical  parameters  in  adolescents  with  and  without
COB  in  each  of  the  pubertal  stages,  statistically  signiﬁcant
differences  were  found  in  pubertal  stage  in  GL  (p  ≤  0.0001),
F
ped the pubertal with the postpubertal states (t-Student).
NS  (p  ≤  0.0001)and  HOMA-IR  (p  ≤  0.0001).  There  were  no
igniﬁcant  differences  in  GL  (p  =  0.7171),  INS  (p  ≤  0.0001)
r  HOMA-IR  (p  ≤  0.0001)  in  the  postpubertal  stage.  When
omparing  the  results  of  adolescents  with  COB  and  the
ubertal  and  postpubertal  stages  there  were  no  signiﬁcant
ifferences  in  GL  (p  =  0.3061),  INS  (p  =  0.8707)  or  HOMA-IR
p  =  0.9734)  values.
The  result  of  the  sensitivity  and  speciﬁcity  analysis
evealed  the  fact  that  HOMA-IR  proved  to  be  a good  pre-
ictor  of  IR  presence  (Fig.  1),  which  reﬂects  a  higher
iscriminating  power  in  the  evaluation  of  this  syndrome.igure  1  The  area  below  the  ROC  curve  of  the  HOMA-IR  as  a
redictor  of  insulin  resistance.
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Table  4  Glucose,  insulin  and  HOMA-IR  by  pubertal  stage  (Tanner)  and  gender.  Saltillo,  Coahuila,  Mexico  (2012--2013).
Pubertal  stage  (Tanner)  n  Glucose  (mg/dL)  Insulin  (UI/mL)  HOMA-IR  (UI/mL  ×  mmol/L)
Average  %a p  Average  %a p  Average  %a p
Female
Prepubertal 4  84.3  ±  10.4 8.2 ** 12.1  ±  5.2 30.3 ** 2.6  ±  1.4 35.3 **
Middle  pubertal 104  81.0  ±  10.6 3.7 <0.0001 12.1  ±  8.6 1.9 0.0133 2.5  ±  2.0 36.7 1
Postpubertal 44  89.0  ±  11.0 16  0.0003* 16.7  ±  13.1 40.1 0.0425 3.9  ±  3.3 59.2 0.9961*
Male
Prepubertal  12  83.3  ±  12.0  8.7  0--0014  10.1  ±  4.2  12.8  0.1196  2.2  ±  1.0  17.3  0.2276
Middle pubertal  112  88.7  ±  12.4  18  <0.0001  14.0  ±  11.6  8.5  0.325  3.2  ±  2.7  50  0.0379
Postpubertal 16  90.6  ±  4.9  3 <0.0001* 7.6  ±  3.9  0.1  0.0547* 1.7  ±  0.9  5.5  0.0557*
a % of values above the cutoff point. Cutoff points: Glucose ≥100 mg/dL; insulin: prepubertal ≥15 mU/mL, middle pubertal ≥30 mU/mL, postpubertal ≥20 mU/mL; HOMA-IR ≥3.16. For
the value of p we collated the pubertal with the postpubertal states (t-Student).
* ANOVA.
** This statistic was not analyzed because of the low number of n.
Table  5  Glucosa,  insulin  and  HOMA  by  pubertal  stage  (Tanner)  and  waist  circumference.  Saltillo,  Coahuila,  Mexico  (2012--2013).
Pubertal  stage  (Tanner) PC  n  Glucose  (mg/dL) Insulin  (UI/mL) HOMA-IR  (UI/mL  ×  mmol/L)
Average %a p  Average %a p  Average  %a p
Prepubertal  <90  15  82.5  ±  11.0  6  --  10  ±  3.8  9.8  --  2.1  ±  0.9  13.3  --
>90 1  98  --  --  19.6  --  --  4.7  --  --
Middle pubertal  <90  168  83.1  ±  11.9  7.7  <0.0001  10.1  ±  6.4  0.1  <0.0001  2.1  ±  1.4  23.2  <0.0001
>90 48  91.9  ±  10.7  22.5  23.6  ±  13.9  32.5  5.4  ±  3.3  75.3
Postpubertal <90  40  89.8  ±  8.2  10.7  0.7171  9.3  ±  5.3  2.3  <0.0001  2.9  ±  1.7  30.5  <0.0001
>90 20  88.8  ±  12.4  18.7  24.2  ±  15.3  60.8  5.4  ±  3.9  71.8
PC: waist percentile.
a % of values above the cutoff point. Cutoff points: glucose ≥100 mg/dL; insulin: prepubertal ≥15 mU/mL, middle pubertal ≥30 mU/mL, postpubertal ≥20 mU/mL; HOMA-IR ≥3.16.
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MLevels  of  insulin  and  HOMA-IR  in  adolescents  in  Saltillo,  Coa
HOMA-IR  (46%).  These  results  were  higher  than  those
reported  in  adolescents  in  the  same  age  range  for  over-
weightness  (19%)  and  obesity  (13%)  in  Chiapas,  Mexico,5
and  even  lower  than  those  reported  in  adolescents  between
10  and  17  years  with  obesity  (49.2%)  in  Lima,  Peru.1 As
expected,  adolescents  with  obesity  and  central  obesity
showed  signiﬁcantly  higher  INS  and  HOMA-IR  numbers  com-
pared  to  those  adolescents  with  a  normal  BMIz.
In  this  manner,  the  adolescents  without  obesity  mani-
fested  average  values  for  INS  (8  UI/mL)  and  HOMA-IR  (1.8),
and  the  adolescents  with  obesity  had  averages  of  INS  as
21.9  UI/mL  and  HOMA-IR  4.9.  We  would  like  to  point  out
the  fact  that  adolescents  with  morbid  obesity  reached  INS
levels  of  91.6  UI/mL  and  HOMA-IR  values  of  20.3,  values
never  before  reported  in  the  Mexican  population.  These  ﬁnd-
ings  in  adolescents  of  both  genders  conﬁrm  those  reported
by  other  authors  in  the  sense  that  they  observed  a  posi-
tive  relationship  between  IR  and  the  presence  of  obesity
and  that  it  increases  progressively  in  function  of  the  excess
of  weight.1,5--7,37
Regarding  basal  GL  levels,  this  increased  as  BMIz
increased.  We  found  that  the  average  levels  are  greater
in  males  than  in  females,  just  as  reported  by  Souki-Rincón
et  al.22
Similar  to  other  studies  previously  conducted,  we  found
in  ours  that  INS  concentrations  are  higher  in  female  adoles-
cents  than  in  males.21 In  this  study,  approximately  2  out  of
every  10  adolescents  with  overweightness  and  7  out  of  10
with  obesity  displayed  IR,  the  male  gender  being  the  most
affected.  A  signiﬁcant  correlation  between  INS  concentra-
tions  and  HOMA-IR  was  found,  which  was  expected,  because
HOMA-IR  values  are  derived  from  INS  and  GL  concentrations.
Antropometric  measurements,  BMIz,  and  WC  are  indepen-
dently  associated  with  GL,  INS  and  HOMA-IR  levels.  We  were
able  to  observe  that  WC  predicted  these  variables  more
accurately  in  comparison  to  BMIz.
Furthermore,  given  the  fact  that  INS  and  HOMA-IR  con-
centrations  followed  the  same  distribution,  we  were  able  to
consider  the  latter  as  a  meter  to  be  as  good  as  basal  INS  to
establish  IR.  Keskin  et  al.  showed  that  HOMA-IR  had  a  high
speciﬁcity  and  sensitivity  for  IR  measurement  in  children  and
adolescents.36
The  prevalence  of  IR  found  in  the  studied  population
(46%)  exceeds  that  reported  by  Acosta  et  al.7 These  authors
also  used  HOMA-IR  values  higher  than  3.1  for  an  IR  diag-
nosis.  On  the  other  hand,  it  was  found  that  approximately
half  of  the  adolescents  in  the  postpubertal  state  (IV  and
V)  displayed  higher  levels  of  INS  and  HOMA-IR.  When  ana-
lyzing  pubertal  stage  by  gender,  the  highest  values  of
chemical  parameters  were  found  in  females  in  the  post-
pubertal  (IV  and  V)  and  males  with  pubertal  stage  (II  and
III).  Rojas-Gabulli  et  al.1 suggested  that  IR,  which  results
in  hyperinsulinemia,  according  to  Arslanian  and  Kalhan38
is  observed  between  Tanner  stages  II  and  IV.  These  results
agree  with  our  results.  Also,  IR  found  in  the  study’s  adoles-
cents  was  lower  than  that  reported  by  Kurtoglu  et  al.39 in
adolescents  in  the  prepubertal  (male  37%  and  female  27.8%)
and  pubertal  stages  (male  61.7%  and  female  66.7%).  These
differences  are  based  on  the  fact  that  these  authors  utilized
different  reference  values  according  to  gender  and  sexual
maturation  stage  for  their  IR  diagnosis,  using  the  follow-
ing  HOMA-IR  values:  for  the  prepubertal  stage  the  following
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alues  were  used:  male  2.67  and  female  2.22,  and  for  the
ubertal  stage:  male  5.22  and  female  3.82.  Thus,  we  present
he  need  to  continue  conducting  studies  on  adolescents,
llowing  the  establishment  of  normal  levels  for  INS  as  well  as
or  HOMA-IR.  The  highest  insulin  and  HOMA-IR  values  were
bserved  in  adolescents  with  COB.  Moreover,  the  incidence
f  higher  INS  and  HOMA-IR  values  were  observed  in  adoles-
ents  with  COB  in  the  pubertal  and  postpubertal  stages,  like
ther  authors.7,39 The  evaluation  of  HOMA-IR’s  ability  to  pre-
ict  an  IR  diagnosis  through  the  analysis  of  the  ROC  curve,
ndicates  that  it  has  a  high  sensitivity  and  speciﬁcity  for  this
urpose.
The  main  strengths  of  this  study  are  the  homogeneity  of
he  conditions  at  which  samples  were  taken,  conducting  sim-
le  non-invasive  studies  like  WC  (waist  circumference)  BMIz,
NS,  basal  GL  and  HOMA-IR,  and  HOMA-IR  being  a  high  sensi-
ivity  and  speciﬁcity  indicator.  The  limitations  of  this  study
re  the  following:  since  it  is  a  relatively  small  demographic
ample,  it  was  not  necessarily  a  sample  representative  of
he  population  of  the  same  age  intervals  (however,  it  may
erve  for  comparison  of  other  Mexican  adolescents);  not
aving  cutoff  points  in  HOMA-IR  for  Mexican  adolescents  of
ifferent  ages  and  pubertal  stages,  and  not  having  a  bal-
nced  representative  number  for  each  one  of  the  pubertal
aturation  stages.
onclusion
his  study  shows  a  high  OW,  OB  and  COB  incidence.  It
evealed  a  positive  correlation  between  the  rise  in  GL,  INS
nd  HOMA-IR  levels  and  the  rise  of  BMIz  and  COB,  showing  a
igh  IR  incidence.  Therefore,  OW,  OB,  COB  and  HOMA-IR  can
e  used  as  a  reference  in  clinical  practice  for  IR  diagnosis  and
an  be  signiﬁcant  predictors  of  DM2.  These  data  highlight  the
mportance  of  early  IR  detection  in  adolescents  with  OW,  OB,
nd  COB,  and  stress  the  importance  of  managing  early  inter-
ention  strategies,  which  allow  the  identiﬁcation  of  IR  risk,
or  its  timely  management  and  prevention  of  DM2,  CVD  and
S  development.
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